- Reuters via Yahoo FinanceMay 20 20:59 PM
Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the treatment as a monotherapy in patients ...
- Reuters via Yahoo Finance3 hours ago
- ABC News via Yahoo News30 minutes ago
- Market Watch27 minutes ago
- Zacks via Yahoo FinanceMay 20 13:02 PM
AbbVie, Inc. ABBV announced that a late-stage study evaluating its pipeline candidate, depatuxizumab mafodotin (Depatux-M) failed to show any survival benefit in patients with newly diagnosed ...
- Zacks via Yahoo FinanceMay 20 13:15 PM
A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price.
- Benzinga via Yahoo FinanceMay 20 18:28 PM
Bristol-Myers Squibb Co (NYSE: BMY)'s quest to expand its oncology franchise through its proposed acquisition of Celgene Corporation (NASDAQ: CELG) may not be a wise move, according to ...
- Reuters via Yahoo FinanceMay 20 11:46 AM
Canada Pension Plan Investment Board said it had paid about $1.3 billion for a part of British charity LifeArc's royalty interest from the sale of Merck & Co Inc's blockbuster ...
- related to MERCK & CO., INC